---

To mark the occasion of World Tuberculosis (TB) Day, on March 24, the Union Ministry of Ayush in partnership with the Department of Biotechnology (DBT), Ministry of Science & Technology announced a collaborative clinical study titled “Clinical Study on Ayurveda as an Adjunct Therapy for Tuberculosis”.

The announcement was made by Dr. Jitendra Singh, Minister of State (Independent Charge), Ministry of Science and Technology and Ministry of Earth Sciences and Prataprao Jadhav, Minister of State (Independent Charge) of the Ministry of Ayush and Minister of State in the Ministry of Health & Family Welfare in the presence of senior officials and scientists of the Ministries. The event held at Vigyan Bhawan, brought together policymakers, scientists, scholars, researchers, clinicians, and other key stakeholders to underscore India’s commitment to evidence-based integration of traditional and modern medicine to fight tuberculosis.

Dr. Jitendra Singh said, “The launch of this collaborative clinical study reflects our commitment to science-led, evidence-based innovation, integrating modern biomedical research with validated traditional knowledge systems. Through initiatives led by the Department of Biotechnology, we are strengthening research, fostering global partnerships, and advancing patient-centric solutions to address challenges such as drug resistance, undernutrition, and long-term health impacts of TB.”

Prataprao Jadhav said, “The treatment of tuberculosis is not only about eliminating the infection, but also about curing the patient. Thus, Ayush systems will support treatment and play an important role in improving recovery, nutrition, and the patients’ quality of life too.”

Led by the Central Council for Research in Ayurvedic Sciences (CCRAS) in partnership with DBT, the multi-centre study will assess the efficacy, safety, and tolerability of an Ayurveda regimen as an adjunct to standard Anti-Tuberculosis Treatment (ATT), along with nutritional support. To be conducted across premier institutions including AIIMS, JIPMER, and NEIGRIHMS, the 24-month study aims to generate robust scientific evidence on improving nutritional outcomes, accelerating recovery, and enhancing quality of life among TB patients, further strengthening India’s commitment to innovative, patient-centric approaches for TB elimination.

A Memorandum of Understanding (MoU) was exchanged between Prof G Karthikeyan, Executive Director, BRIC-THSTI, and Prof Vaidya Rabinarayan Acharya, DG, CCRAS.

---

Related Articles

An international conference for AYUSH lovers

Ayush Minister, Naik gives away Ayush Awards to health sector entities

Another Meet for Ayurveda Experts

3rd edition of Global Ayurveda Festival

Kerala Ayurveda Promotion Club

Brihanmumbai Muncipal Corporation to start unani, Ayurveda clinics in hospitals